Key Players in India Pancreatitis Market | Top Companies & Insights 2026

India Pancreatitis Market Overview

According to 6Wresearch, the India pancreatitis market is set for significant expansion as healthcare providers prioritize the management of exocrine pancreatic insufficiency (EPI). The treatment, which largely consists high-potency pancreatin and multimodal pain management, is crucial for addressing issues caused by chronic alcohol consumption and biliary gallstones. The market is an evolving ecosystem that utilizes advanced chemical synthesis, sophisticated enteric coating facilities, and extensive gastro-retail networks to serve millions of patients.

Competitive Landscape

The competitive landscape of the India pancreatitis market is characterized by a mix of global leaders with heritage brands and agile domestic firms offering high-strength enzyme variants. Intense R&D investment is made to develop acid-resistant enzyme delivery devices and cost-effective combination medicines that contain biliary ingredients. Strategic marketing partnerships are increasingly common as firms aim to penetrate tier-2 and tier-3 cities where diagnostic rates for chronic abdominal conditions are rising.

Below is a list of leading players operating in the India Pancreatitis Market:

1. Abbott Laboratories

The global innovator of the gold-standard Creon brand, utilizing Minimicrosphere technology to ensure superior enzyme distribution and nutrient absorption.

2. Sun Pharmaceutical Industries Limited

Provides the high-performance Panlipase brand, ensuring widespread availability across India through its dominant domestic distribution network.

3. Torrent Pharmaceuticals Limited

A key player in the gastro-intestinal segment with its Enzar and Enzar-HS capsules, favored for high-strength pancreatin content.

4. Sanofi S.A.

Markets the classic Festal N brand, which combines pancreatin with bile constituents to facilitate effective fat digestion in chronic patients.

5. Dr. Reddy's Laboratories Ltd.

Focuses on precision therapy with its Agna brand of delayed-release capsules, catering specifically to patients with severe pancreatic enzyme deficiencies.

6. Lupin Limited

Offers the Lupase range, known for its balanced enzyme ratio and affordability, making it a popular choice for long-term maintenance therapy.

7. Zydus Lifesciences Limited

Produces Panzynorm-HS, utilizing advanced enteric coating technology to prevent enzyme degradation by gastric acids in the stomach.

8. La Renon Healthcare Pvt. Ltd.

A high-growth specialist firm that provides Pancrehenz, focusing on the chronic kidney and liver-related complications of pancreatitis.

9. Shreya Life Sciences Pvt. Ltd.

A notable player in the digestive health market, offering specialized enzyme formulations tailored for the Indian dietary profile.

10. Taj Pharmaceuticals Ltd.

A major manufacturer and exporter of generic Pancreatin BP tablets, supplying high-purity enzymes to bulk buyers and hospitals globally.

11. Viatris Inc.

Formed through the merger of Mylan and Upjohn, it provides a diverse portfolio of digestive health products and enzymes to the Indian market.

12. MSN Laboratories

An API powerhouse that supplies critical active ingredients and finished formulations like Enzase to the domestic and international markets.

13. Micro Labs Limited

Offers high-quality pancreatic enzyme supplements and supportive therapies through its extensive network in the Indian gastroenterology sector.

14. USV Private Limited

Utilizes its deep expertise in chronic care to distribute advanced enzyme therapies through its established network of specialist practitioners.